CCL18 and EGF May Serve as Potential Prognostic Biomarkers and Therapeutic Targets for Human Breast Cancer

International Journal of Breast Cancer · Published 2025-01-01 · DOI 10.1155/ijbc/8856457

Authors being retrieved — see the publisher record. https://doi.org/10.1155/ijbc/8856457

Abstract

Conclusion: CCL18 shows strong prognostic and immunological relevance in BRCA, while EGF appears to play a broader oncogenic role. Hypomethylation of both genes may drive their aberrant expression and involvement in tumor progression.

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year
2025

Related articles